|
1
|
Fransecky L, Mochmann LH and Baldus CD:
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Mol Cell
Ther. 3:22015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Annesley CE and Brown P: Novel agents for
the treatment of childhood acute leukemia. Ther Adv Hematol.
6:61–79. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galloway-Peña JR, Smith DP, Sahasrabhojane
P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji
SS, Pemmaraju N, et al: The role of the gastrointestinal microbiome
in infectious complications during induction chemotherapy for acute
myeloid leukemia. Cancer. 122:2186–2196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jain S, Self WH, Wunderink RG, Fakhran S,
Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM,
et al CDC EPIC Study Team, : Community-acquired pneumonia requiring
hospitalization among U.S. adults. N Engl J Med. 373:415–427. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gopakumar KG, Priyakumari T and
Kusumakumary M: Infectious complications during induction
chemotherapy in children with acute myeloid leukemia. Pediatr
Hematol Oncol J. 1:S152016. View Article : Google Scholar
|
|
6
|
Avdonina MA, Abramov IS, Ammour YI and
Nasedkina TV: Allelic variants of immune response genes in children
with infectious complications during the treatment of acute
leukemia. Mol Biol (Mosk). 51:301–307. 2017.(In Russian).
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Saleno CH, Camacho JR, Neto LM and
Mendonca RG: P-177: The Sequential Organ Failure Assessment (SOFA)
score is a predictive factor for 14-day mortality of elderly
patients with advanced cancer who present to the ED. Eur Geriatr
Med. 2015:S79. 1959.
|
|
8
|
Bleakley M, Heimfeld S, Loeb KR, Jones LA,
Chaney C, Seropian S, Gooley TA, Sommermeyer F, Riddell SR and
Shlomchik WD: Outcomes of acute leukemia patients transplanted with
naive T cell-depleted stem cell grafts. J Clin Invest.
125:2677–2689. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knaus HA, Kanakry CG, Luznik L and Gojo I:
Immunomodulatory drugs: Immune checkpoint agents in acute leukemia.
Curr Drug Targets. 18:315–331. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bigliardi S, Morselli M, Potenza L, Riva
G, Coluccio V, Maccaferri M, Paolini A, Colaci E, Fantuzzi V, Soci
F, et al: Epidemiology and clinical outcome of lower respiratory
tract infections by respiratory syncytial virus or parainfluenza
virus type 3 in adults receiving treatment for either acute
leukemia or severe aplastic anemia: A retrospective single center
study. Ann Hematol. 94:1931–1934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shokouhi S, Tehrani S and Hemmatian M:
Mixed pulmonary infection with Penicillium notatum and Pneumocystis
jiroveci in a patient with acute myeloid leukemia. Tanaffos.
15:53–56. 2016.PubMed/NCBI
|
|
12
|
Nie W, Huang Q, Chen Y and Yin X:
Treatment of an elderly patient with acute myeloid leukemia and
invasive pulmonary aspergillosis infection with combined allogeneic
hematopoietic stem cells microtransplantation and voriconazole.
Indian J Hematol Blood Transfus. 32 Suppl 1:56–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hakim H, Dallas R, Zhou Y, Pei D, Cheng C,
Flynn PM, Pui CH and Jeha S: Acute respiratory infections in
children and adolescents with acute lymphoblastic leukemia. Cancer.
122:798–805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sadarangani M, Harvey M, McDonald A,
Speert DP and Dix D: Brain abscesses due to Aspergillus nidulans
infection during induction chemotherapy for acute lymphoblastic
leukemia. J Pediatr Hematol Oncol. 37:e384–e386. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kurai D, Sasaki Y, Saraya T, Ishii H,
Tsukagoshi H, Kozawa K, Ryo A, Ishioka T, Kuroda M, Oishi K, et al:
Pathogen profiles and molecular epidemiology of respiratory viruses
in Japanese inpatients with community-acquired pneumonia. Respir
Investig. 54:255–263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Çolak A, Yılmaz C, Toprak B and Aktoğu S:
Procalcitonin and CRP as biomarkers in discrimination of
community-acquired pneumonia and exacerbation of COPD. J Med
Biochem. 36:122–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rodríguez AH, Avilés-Jurado FX, Díaz E,
Schuetz P, Trefler SI, Solé-Violán J, Cordero L, Vidaur L, Estella
Á, Pozo Laderas JC, et al SEMICYUC/GETGAG Working Group, :
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in
ICU patients with influenza: A CHAID decision-tree analysis. J
Infect. 72:143–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chou SC, Ko HW and Lin YC: CRP/IL-6/IL-10
Single-nucleotide polymorphisms correlate with the susceptibility
and severity of community-acquired pneumonia. Genet Test Mol
Biomarkers. 20:732–740. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fukumoto K, Taniguchi T, Usami N,
Kawaguchi K, Fukui T, Ishiguro F, Nakamura S and Yokoi K:
Preoperative plasma D-dimer level is an independent prognostic
factor in patients with completely resected non-small cell lung
cancer. Surg Today. 45:63–67. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Duarte JC, Tavares e Castro A, Silva R,
Correia L, Simão A and Carvalho A: Prognostic value of plasma
D-dimer level in adults with community-acquired pneumonia: A
prospective study. Rev Port Pneumol 2006. 21:218–219.
2015.PubMed/NCBI
|
